1 Board Review: Hypertension Cases Cheryl L. Laffer, MD, PhD, FAHA Associate Professor of Medicine, Texas A&M HSC College of Medicine Senior Staff, S&W Nephrology / Hypertension
2 (Remember, I didn t make these up.)
3 Nephro Q yo woman referred for evaluation of BP 150/94. Nurse-husband measures BP at home, always / Nonsmoker; mother has hypertension. PE: average BP 148/98. Remainder & labs unremarkable. Counseled on lifestyle modification.
4 Q 13: Which of the following is the most appropriate management of this patient? A. Begin HCTZ. B. Begin enalapril. C. Perform ambulatory blood pressure monitoring. D. Continue home blood pressure measurement.
5 Nephro Q yo woman evaluated for newly diagnosed hypertension. +FHx essential hypertension, both parents diabetic. PE: BP 150/95, BMI=32; remainder normal. Labs: Normal electrolytes, BUN & Creat; fasting glucose 90, TChol 220, TG 250, HDL 35, LDL 140. BP elevation confirmed on repeat and counseled on lifestyle modification.
6 Q 66: Which of the following is the most appropriate treatment of this patient's hypertension? A. Hydrochlorothiazide. B. Doxazosin. C. Atenolol. D. Irbesartan.
7 Nephro Q yo black man evaluated for hypertension. Years previously told of elevated BP at health fair.?therapy initiated, discontinued after 3 months because of side effects. His blood pressure at local grocery stores is approximately 160/90 mm Hg. PE: BP 158/88, pulse 64. Fundi: hypertensive retinopathy. 1+ lower-extremity edema. Labs: Hgb 11.8, Na 142, K 3.9, Cl 110, TCO 2 22, BUN 34, Creat 1.9; Uric Acid 8.2, Ca 10.1, Ph 4.0; UA 2+ protein, no blood, Pro:Creat = Renal US: R 9.2, L 9.1 cm with 2 simple cysts; echogenic.
8 Q 61: Which of the following is the most appropriate treatment of this patient's hypertension? A. Ramipril. B. Metoprolol. C. Amlodipine. D. Terazosin.
9 Critical Care Q yo man admitted to ICU after 3-months frequent headache and progressive SOB. Hx hypertension for 25 yrs, multiple TIAs, and DM2; s/p CABG and aorto-bifem bypass. Recent 2-pillow orthopnea and PND, without angina. Current Rx metoprolol, lisinopril, amlodipine, hydrochlorothiazide, and glyburide. PE: BP 210/130, pulse 60. JVP 12 cm; right carotid artery bruit. Bibasilar crackles, +S4, 2/6 EKG: SB, LVH + strain. Labs: normal. Improves with IV diuretics, DBP ; still with headache, but nonfocal exam.
10 Q 84: Which of the following is the most appropriate next step in the evaluation of this patient? A. Head CT. B. Cardiac cath. C. Renal ultrasound with Dopplers. D. 24 hr urine for VMA and metanephrines.
11 Nephro Q yo woman evaluated for resistant hypertension. Despite 20 years of treatment, blood pressure usually about 160/90. For several years she had been taking amlodipine 10 mg and metoprolol 100 mg/d. Recently changed to lisinopril 20 mg and verapamil SR 180 mg/d. PE: BP 168/100, pulse 68. PMI prominent and laterally displaced. Lungs clear, remainder normal. Labs: Na 147, K 3.3, Cl 100, TCO2 28, BUN 18, Creat 0.9. Echocardiogram: increased LV mass.
12 Q 30: Which of the following is the most appropriate next step in the management of this patient? A. MRA. B. HCTZ 25 mg/d. C. Aldosterone-renin ratio. D. CT scanning.
13 Nephro Q yo woman with a longstanding history of poorly controlled hypertension is evaluated for primary aldosteronism. PE: BP 176/105. Cardiac: +S3. Lungs clear. Labs: PRA=0.06 nga I /ml/hr, 24hr urine Aldosterone=18 µg. Adrenal CT: L gland solitary 1.5 cm nodule, R gland normal/slightly enlarged.
14 Q 38: Which of the following is the most appropriate next step in the management of this patient? A. Laparoscopic L adrenalectomy. B. Adrenal vein sampling for aldo & cortisol. C. Renal arteriography. D. Dexamethasone suppression test.
15 Nephro Q yo man with 30 yrs hypertension that has become more difficult to control last 2 years. Over the last 6 months, his blood pressure measurements have ranged from 150/70 mm Hg to 170/90 mm Hg. Medications are atenolol 50 mg/d, enalapril 20 mg twice daily, and hydrochlorothiazide 25 mg/d. PE: BP 168/80, pulse 66 - same x3 appointments, faint midline and L femoral bruits. Creat 1.1 [stable x2 yrs], LDL 160.
16 Q 55: Which of the following is the most appropriate management at this time? A. Renal angiography. B. Amlodipine. C. Measure PRA. D. Renal vein renin sampling. E. MRA of renal arteries.
17 Nephro Q yo male smoker with CAD, PAD, CKD [egfr=45] and uncontrolled hypertension, recently hospitalized for acute pulmonary edema. Medications are ASA 81 mg, simvastatin 40 mg, carvedilol 25 mg b.i.d., furosemide 40 mg b.i.d., losartan 100 mg, amlodipine 5 mg, clonidine 0.2 mg b.i.d., and digoxin mg. daily. PE: BP 186/72, pulse 62, +S4, abdominal bruit, 1+ edema bilaterally. Renal US: left kidney 8.5 cm, right kidney 11 cm with increased echogenicity.
18 Q 70: Which of the following is the most appropriate next step in management? A. Increase amlodipine to 10 mg. B. MRA of abdomen. C. Discontinue carvedilol. D. Add lisinopril. E. CT of abdomen with IV contrast.
19 Nephro Q yo woman with resistant hypertension and fatigue, home BP typically 180/70. Medications are metoprolol 50 mg, lisinopril 20 mg, and HCTZ 12.5 mg daily. PE: BP 180/70, pulse 72. Labs: Na 132, K 3.3, Cl 99, TCO2 26, BUN 12, Creat 0.9, PRA 0.36 ngai/ml/hr.
20 Q 72: Which of the following is the most appropriate next step in management? A. Double the HCTZ. B. Double the metoprolol. C. Double the lisinopril. D. Discontinue HCTZ, add spironolactone 25 mg/d.
21 Nephro Q yo man with DM2 presents with chest pain, abnormal stress test and hypertension. Medications are metformin, alpha-beta blocker, ACE-inhibitor, aspirin and statin. PE: BP 160/90; early diabetic retinopathy. Labs: BUN 15, Creat 1.1, K 5.2, spot urinary albumin:creatinine ratio = 175 mg/g. Cardiac cath: mild-moderate diffuse triple vessel disease not amenable to revascularization.
22 Q 90: Which of the following is indicated to treat his hypertension? A. Angiotensin Receptor Blocker. B. Thiazide. C. Alpha-blocker. D. K-sparing diuretic.
23 Nephro Q yo black man with inadequately controlled hypertension on HCTZ 25 mg/d. PE: BP 150/90, BMI=28; remainder normal. Labs: glucose 90, Creat 1.3, K 3.6, spot urinary albumin:creatinine ratio = 10 mg/g.
24 Q 80: Which of the following is the most appropriate treatment for this patient? A. Increase the thiazide dose. B. Add atenolol. C. Add an ACE-inhibitor. D. Add a dihydropyridine calcium-channel blocker.
25 Nephro Q yo man with hypertension and diabetic nephropathy, diabetes x10 yrs; no shortness of breath or edema. Medications are glipizide 5 mg b.i.d., pioglitazone 30 mg, metoprolol 100 mg, fosinopril 80 mg, HCTZ 25 mg, atorvastatin 40 mg and aspirin 81 mg daily. PE: BP 145/85, pulse 55, obese; retinal microaneurysms, CV unremarkable, trace edema. Labs: Creat 1.0, Na 140, K 4.0, Cl 106, TCO2 24; 24hr urine protein 6 g; U/A 4+ protein, 1-2 RBCs, 8 WBCs. U/S: R kidney 12 cm, L 12.2; normal echogenicity without hydronephrosis, masses or stones.
26 Q 11: Which of the following is the most appropriate next step in management? A. Double the HCTZ. B. Add amlodipine. C. Add prazosin. D. Increase metoprolol to 150 mg/d. E. Add losartan.
27 Nephro Q yo man with chronic hypertension, diagnosed with osteoarthritis 20 yrs ago. Medications are atenolol 50 mg and HCTZ 25 mg daily. Last year added ibuprofen 200 mg q.i.d. PE: BP 180/90, pulse 60, not orthostatic; trace peripheral edema. Labs: BUN 40, Creat 1.5, Na 134, K 4.9.
28 Q 9: Which of the following treatment strategies is indicated? A. Increase the atenolol dose. B. Increase the thiazide dose. C. Add lisinopril. D. Discontinue ibuprofen.
29 Nephro Q yo woman with longstanding hypertension well controlled with β-blocker therapy. Prior PCP recently passed away, and BP high at new MD s office. Records show BP always normal with prior MD. Unable to tolerate ACE-inhibitors, ARB, dihydropyridine CCB. Now has fatigue, weakness, and dizziness, particularly after standing up, on metoprolol 50 mg and hydrochlorothiazide 25 mg/d. PE: BP 170/70, pulse 60, supine and standing. Remainder unremarkable. Na 136, K 3.6, TCO 2 26, BUN 18, Creat 0.8, Glu 78.
30 Q 20: Which of the following is the most appropriate next step in the management of this patient? A. MRA of the renal arteries. B. Increase HCTZ to 50. C. Discontinue metoprolol. D. Perform ambulatory blood pressure monitoring.
Approaches to the Management of Difficult-to-Control Theodore D Fraker, Jr, MD Professor of Medicine The Ohio State University Medical Center Orlando, Florida October 7-9, 2011 Case Study: DM 64 year old
Diabetes Mellitus 1 Chapter 43. Diabetes Mellitus, Self-Assessment Questions 1. A 46-year-old man presents for his annual physical. He states that he has been going to the bathroom more frequently than
Overview Hypertension Guidelines Aim to reduce Blood Pressure to 140/90 or less (140/80 for diabetics), adding drugs as needed until further treatment is inappropriate or declined. N.B. patients do not
Quiz 5 Heart Failure summary statistics The correct answers to questions are indicated by *. Students were awarded 2 points for question #3 for either selecting spironolactone or eplerenone. However, the
Case Presentation: Mr. E.M. Dr. Braun Case Presentation: Mr. E.M. 66 years old; PMHx CAD with stent 2010; carotid artery disease with stent 1999; aortic stenosis; CVA 1998; type 2 DM; colon cancer with
Managing BP to Goal in Adults with Diabetes Patrick J. O Connor MD MPH Senior Clinical Investigator HealthPartners Research Foundation 70% of type 2 diabetes die of a heart attack or stroke Reduce heart
Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension
Hypertension and Heart Failure Medications Dr William Dooley Plan Heart Failure Acute vs. chronic Mx Hypertension Common drugs used Method of action Choice of medications Heart Failure Aims; Short term:
EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS Steven T. Johnson, PhD 1 Introduction The prevalence of chronic diseases like cardiovascular
Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) Adapted by Capital Health Plan Approved by Quality Improvement
United Indian Health Services Blood Pressure Medication Titration Program Barbara Pfeifer Diabetes Programs Manager Why a Medication titration program? Despite the many antihypertensive medications available,
Case Study 6: Management of Hypertension 2000 Scenario Mr Ellis is a fit 61-year-old, semi-retired market gardener. He is a moderate (10/day) smoker with minimal alcohol intake and there are no other cardiovascular
Current Strategies in Hypertension: Getting Ready for JNC 8 Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Summary of Presentation
JNC 8: Relaxing the Pressure in the Hypertension Guidelines Ashley Lawrance, Pharm.D. PGY1 Pharmacy Practice Resident Peninsula Regional Medical Center Salisbury, MD Learning Objectives Describe updated
Patricia F. Kao MD MS Asst Professor, EVMS Nephrology & HTN April 26, 2014 The Hypertension Treatment Center I have no conflicts of interest to disclose Objectives Describe the role of Hypertension Treatment
Cardiovascular System & Its Diseases Lecture #4 Heart Failure & Cardiac Arrhythmias Dr. Derek Bowie, Department of Pharmacology & Therapeutics, Room 1317, McIntyre Bldg, McGill University firstname.lastname@example.org
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
California Association of Nurse Practitioners March 18, 2016 INSULIN THERAPY AND YOUR PRACTICE BY ZARMINE NACCASHIAN PHD, GNP, RN, CDE BARRIERS TO INSULIN INITIATION Clinician "Clinical inertia High: slow
Current Strategies in Hypertension: Getting Ready for JNC 8 Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Summary of Presentation
Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,
THE MUSCLE AND CARDIOVASCULAR SYSTEM The focus of this week s lab will be pathology of the cardiovascular system. The cardiovascular system is composed of the heart and its associated structures as well
Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:
Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
DIABETES FACT SHEET IN KOREA 2013 DIABETES FACT SHEET IN KOREA 2013 SUMMARY Among adults aged 30 years and older, about 4 million Koreans (12.4%) had diabetes in 2011. 20% of Korean adults were diagnosed
MEDICATIONS COMMONLY USED IN CHRONIC KIDNEY DISEASE HealthPartners Kidney Health Clinic 2011 People with chronic kidney disease (CKD) require multiple medications. This handout will help explain the reason
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Elhami et al. SJIF Impact Factor 5.210 Volume 4, Issue 11, 1159-1166 Research Article ISSN 2278 4357 DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE
Appendix 2B Heart Failure Prescribing Guidelines Rotherham PCT Applicable to: Carvedilol in the Treatment of Heart Failure All patients diagnosed with and commenced on carvedilol. Patients not discharged
Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Naftali Stern Institute of Endocrinology, Metabolism and Hypertension Tel Aviv -Sourasky Medical Center and Sackler
Hull & East Riding Prescribing Committee PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION For guidance on Primary Prevention please see NICE guidance http://www.nice.org.uk/guidance/cg181
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
65 yo male with multiple myeloma develops dyspnea on exertion and peripheral edema. HR 80, BP 120/70. JVP > 15cm H2O. Echo notable for increased wall thickness, scintillation appearance, LVEF 50%, +1 MR
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
Why we need to code well! Coding to be more efficient and accurate Diabetes without Complication Diabetes with opthamologic or unspecified complication Diabetes with acute complication $1833 $2931 $3836
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
Nursing Care and Considerations for Patients with Atrial Fibrillation Kris Kinghorn RN, MSN, ANP-BC Case Study 66 y/o female (Mrs. Olus A. Blader) Admitted with c/o palpitations and lightheadedness PMH:
DISCLOSURES I have no relevant financial relationships to disclose. Cardiac Evaluation of Potential Solid Organ Transplant Recipients Michele Hamilton, MD Director, Heart Failure Program Cedars Sinai Heart
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics Yen Tibayan, M.D. Division of Cardiovascular Medicine Case Presentation 69 y.o. woman calls 911 with the complaint of
Open the Flood Gates Urinary Obstruction and Kidney Stones Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke Nephrology vs. Urology Nephrologist a physician who has been trained in the diagnosis
Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.
AMBULATORY CARE SERVICES Roda Plakogiannis, BS, PharmD, BCPS, CLS Associate Professor of Pharmacy Practice Arnold & Marie Schwartz College of Pharmacy and Health Sciences & Clinical Pharmacy Manager-Primary
Tips and tricks in hypertension Domenic Sica, M.D. Professor of Medicine and Pharmacology Chairman, Section of Clinical Pharmacology and Hypertension Division of Nephrology Virginia Commonwealth University
Title: Date: April 2008 MINISTRY OF HEALTH AND LONG-TERM CARE Primary Health Care Team FACT SHEET HEART FAILURE MANAGEMENT INCENTIVE Eligible Patient Enrolment Models (PEMs): Family Health Networks (FHNs)
A WorkLife4You Guide Heart Attack: What You Need to Know What is a Heart Attack? The heart works 24 hours a day, pumping oxygen and nutrient-rich blood to the body. Blood is supplied to the heart through
RENAL ARTERY STENOSIS Grand Rounds 12/20/12 55 y.o Male with PMHx of hypertension, CKD stage III, PVD s/p bilateral common iliac artery stent 5 years ago, renal artery stenosis referred to vascular surgery
Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research? Jody Dushay, MD MMSc Beth Israel Deaconess Medical Center Boston, MA Session 445 No disclosures Disclosure Jody Dushay,
SAVE ON MEDICAL SERVICES and PRESCRIPTION DRUGS for ongoing conditions With Dickinson College s Value Based Insurance Design (VBID) If you have an ongoing condition, you can live well. You will need to
Combination Antihypertensive Therapy: When to use it Diabetes George L. Bakris, MD, F.A.S.N., F.A.S.H. Professor of Medicine Director, ASH Comprehensive Hypertension Center The University of Chicago Medicine
RESTRICTIVE CARDIOMYOPATHY Restrictive cardiomyopathy (RCM) is a rare form of heart muscle disease that is characterized by restrictive filling of the ventricles. In this disease the contractile function
Hypertension: Justifying Those Ridiculously Complex Blood Pressure Tables Lucile Packard Children s Hospital Pediatric Residency Training Program Renal Learning Topics for Residents Abanti Chaudhuri, MD
Salman Bin AbdulAziz University College Of Pharmacy PAH Therapeutics II PHCL 430 Ahmed A AlAmer PharmD R.W. is a 38-year-old obese woman who presents with increasing symptoms of fatigue and shortness of
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising
HEART FAILURE CASE Patient and Setting: Chief Complaint: AS, a 64-year-old woman; emergency department Over the past couple of weeks, I sometimes wake up short of breath. Last night, I woke up 3 times.
Chronic Kidney Disease: Proposed Revisions to the ICD-9-CM Classification Lesley Stevens MD Tufts-New England Medical Center National Kidney Foundation Objectives Kidney Failure Stages of Chronic Kidney
Continuity Clinic Educational Didactic December 8 th December 12 th MKSAP Question 1 A 60-year-old man is evaluated for a 1-year history of generalized fatigue and lack of energy. He has had erectile dysfunction
Quality Indicators Primary Care Quality Care Indicators - Accuro EMR Prevention Data needs to be entered as indicated in order to auto populate the worksheet Date of colon cancer screening Exemption from
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING
MANAGEMENT OF CHRONIC KIDNEY DISEASE IN ADULTS KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family
What s new in the hypertension management? R. Brenner, OA Kardiologie, KSSG 2 Case report: 55yo woman 55yo secretary GP consultation because upper respiratory tract infection Risk factors Diabetes type
Statins: Can there be too much of a good thing? Spoiler alert No Oh Contraire Haaaaiiiiiiile No! Frequently under prescribing statin therapy! Typical Case 68 YO Smoker ACS Multiple prior PCI s Multiple
University Hospitals of Leicester NHS Trust Leicester General Hospital a patients guide Renal Services & Urology Directorate Diabetic Nephropathy 3/05/JP Questions regularly asked by Patients What do Kidneys
Heart Failure: Diagnosis and Treatment Approximately 5 million people about 2 percent of the U.S. population are affected by heart failure. Diabetes affects 20.8 million Americans and 65 million Americans
MEDICARE RISK ADJUSTMENT A PROSPECTIVE APPROACH TO RISK ADJUSTMENT AND ACCURATE DOCUMENTATION AND CODING WHAT IS RISK ADJUSTMENT? Risk Adjustment ensures that accurate payments are made to Medicare Advantage
Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation On the following pages are a number of questions asking about the conditions under which you would prescribe anticoagulation
Geriatric Cardiology: Challenges and Strategies No financial disclosures Geriatrics -- No Specific Age 'you know it when you see it' Functional Status Polypharmacy Impaired Renal Function Diagnostic Testing:
Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis. Thomas Lund Johansen (email@example.com) Andreas
TYPE 2 DIABETES IN THE CHILD AND ADOLESCENT DR. Trinh Thi Kim Hue CONTENTS Definition Diagnosis Treatment Comorbidities and Complications Comorbidities and Complications Screening for T2D References DEFINITION
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate
Hypertension and Diabetes C.W. Spellman, D.O., Ph.D., FACOI Professor & Associate Dean Research Dir. Center Diabetes & Metabolic Disorders Texas Tech University Health Science Center Midland-Odessa, Texas
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Chronic-use Medications List by In accordance with subsection 18 (11.1) of Ontario Regulation 201/96 made under the Ontario Drug Benefit
Kidney Disease Dr. Eoin Bergin Consultant Nephrologist Midlands Regional Hospital, Tullamore 10 Years in Tullamore The Kidney has 2 main functions: Maintaining a constant extracellular environment Removing